Basilea Pharmaceutica AG BPMUF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -0.79% | 16.55% | 0.13% | 59.47% | 8.98% |
| Total Depreciation and Amortization | -0.80% | -64.29% | 0.13% | 203.20% | 8.97% |
| Total Amortization of Deferred Charges | -0.81% | 62.04% | 0.13% | -65.60% | 8.94% |
| Total Other Non-Cash Items | -0.79% | 205.67% | 0.14% | -64.66% | 8.98% |
| Change in Net Operating Assets | 0.79% | -283.39% | 0.13% | 1,658.61% | -8.98% |
| Cash from Operations | -0.79% | -50.46% | 0.13% | 74.58% | 8.98% |
| Capital Expenditure | 0.80% | 81.87% | -0.13% | -638.44% | -9.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.87% | 75.35% | -0.21% | -65.07% | -9.09% |
| Cash from Investing | 0.81% | 81.47% | -0.13% | -509.84% | -8.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00% | 108.11% | 0.00% | -63.51% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 26.33% | 0.00% | 52.33% | 0.00% |
| Cash from Financing | 0.79% | 28.56% | -0.13% | 50.44% | -8.98% |
| Foreign Exchange rate Adjustments | 0.00% | 25.53% | 0.00% | -40.30% | -9.84% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -0.79% | -53.05% | 0.13% | 274.21% | 8.98% |